Escitalopram to Placebo in Patients With Localized Pancreatic Cancer

Clinical trial NCT05289830 · TERMINATED

Trial details

NCT number: NCT05289830
Sponsor: Case Comprehensive Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma Periampullary Cancer

Start date: 2022-08-05
Primary completion: 2023-08-27
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.